NEW YORK (GenomeWeb News) - Ciphergen today said second-quarter losses narrowed despite a 24-percent drop in second-quarter revenue.
 
The narrowed loss together with news that Bio-Rad will acquire its proteomics instrument business caused shares in Ciphergen to climb 11 percent, or $.11, to $1.09 in mid-afternoon trading.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.